Fisent Technologies Raises $4.3 Million To Expand GenAI Process Automation For Regulated EnterprisesAugust 11, 2026
Accounting Keenova Reports Second Quarter 2026 Financial ResultsBy AdminBitAugust 11, 20260 XIAFLEX Pipeline Advancing; Positive Phase 3 Plantar Fibromatosis Data Supporting Planned sBLA Submission in Fourth Quarter 2026; Phase 3 Hammer Toe Study Initiation Expected in Third Quarter 2026